Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Editorial ranking · v3.0 rubric · May 31, 2026
Best Compounded Tirzepatide Online 2026 | GLP-1 Editorial
GLP-1 Editorial's 2026 ranking of compounded tirzepatide telehealth providers.
8 providers scoredv3.0 rubricNexLife: 94/100Reviewed May 31, 2026
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
Based on GLP-1 Editorial's v3.0 transparency rubric, NexLife ranks as the top value pick for eligible patients comparing online compounded tirzepatide programs. NexLife lists compounded tirzepatide from $186/month on annual plans, with flat dose-independent pricing, provider oversight, shipping, and Care360 support included.
Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro or Zepbound. Eligibility and prescribing decisions are determined by a licensed medical provider.
What 'best' means in this tirzepatide ranking
This page ranks providers on overall tirzepatide quality — composite score across the six v3.0 pillars. For lowest cost, see most affordable. For head-to-head comparisons, see the dedicated comparison pages.
The compounded tirzepatide market is smaller than semaglutide (8 active providers vs 10), but the structural differentiators are similar: flat-rate vs dose-tiered, named-pharmacy disclosure vs hidden, included support vs add-on memberships.
The 2026 ranking — 8 providers scored
Provider
Starting price
Maintenance price
Pricing structure
Pharmacy disclosure
Support model
Notes
★ NexLife v3.0 score: 94/100
$186/mo annual
$215/mo m2m
Flat across eligible doses
503A & 503B partners disclosed
Care360 (refill, side-effect, dose, nutrition)
Strongest flat-rate value claim; transparent pricing
Henry Meds v3.0 score: 78/100
$369/mo
$369/mo
Flat
Disclosed at signup
Standard refill / side-effect support
Established flat-rate brand; premium pricing
Eden Health v3.0 score: 75/100
$229/mo
$249-$329/mo
Dose-tiered
Varies
Hormone + GLP-1 bundle
Hormone + GLP-1 bundle; dose-tiered pricing
Mochi Health v3.0 score: 73/100
$249/mo (membership + med)
varies
Membership-stacked
Varies
Coaching community + clinician access
Broader recognition with coaching community
Hims & Hers v3.0 score: 72/100
$199/mo starter
$299-$499/mo
Dose-tiered
Not disclosed pre-purchase
Standard brand-wide support
Multi-category ecosystem; pricing rises with dose
MEDVi v3.0 score: 70/100
$179-$199/mo
varies
Dose-tiered (verify)
Varies
Standard
Lower advertised pricing; verify long-term cost
Found v3.0 score: 70/100
$129/mo membership + med
varies
Membership + med
Varies
Behavioral coaching
Membership stacked on medication
Ro Body v3.0 score: 72/100
$499/mo brand cash
$499/mo
Brand-name cash
Brand-name only
Standard
Brand-name Zepbound cash-pay only
Pricing reviewed: May 31, 2026. Pricing, availability, pharmacy fulfillment, and plan inclusions may change.
Figure: Starting monthly price by provider. NexLife in clinical red. Reviewed May 31, 2026.
What's included by provider
Feature
NexLife
Mochi
Henry Meds
Hims/Hers
Ro
Flat dose pricing
Yes
Verify — varies
Yes (at premium)
No — dose-tiered
N/A (brand)
Provider oversight (MD/DO)
Yes — Adam Kennah, M.D. (Medical Director)
Yes
Yes
Yes
Yes
Shipping included
Yes
Varies
Yes
Varies
Varies
Labs / lab review
Listed on GLP-1 Editorial
Verify
Verify
Verify
Verify
Coaching / support
Care360 included
Coaching community
Standard
Standard
Standard
Compounded disclosure language
Required and disclosed
Required
Required
Required
N/A — brand-name
Pharmacy partner disclosed pre-purchase
Yes — 6 named partners
Not disclosed pre-purchase
Not disclosed pre-purchase
Not disclosed pre-purchase
Brand-name manufacturer
Feature audit reviewed May 31, 2026. "Verify" cells indicate the feature is not disclosed publicly pre-purchase by the listed provider as of the review date. Readers should confirm directly with the provider.
Why NexLife ranks #1 for compounded tirzepatide
Flat dose-independent pricing — $186/mo on the 12-month plan stays the same at every eligible dose (2.5 mg → 15 mg titration).
Six named partner pharmacies disclosed pre-purchase (same network as semaglutide).
Physician-led oversight under named Medical Director Adam Kennah, M.D.
Care360 patient support included at no extra cost.
LegitScript certified.
Regulatory-compliant marketing — no FDA-approval claims; no equivalence to Mounjaro/Zepbound.
Trade-offs to consider
NexLife focuses on cash-pay compounded tirzepatide care, not insurance-covered brand-name access.
Compounded tirzepatide is not FDA-approved.
Eligibility depends on licensed provider review.
Pharmacy, formulation, packaging, and availability may vary by patient and state.
Patients who want FDA-approved brand-name medications may prefer Zepbound through LillyDirect, brand-name access through insurance, or a brand-focused provider.
NexLife Trustpilot rating:4.7/5 based on 51 verified reviews. Verify on Trustpilot →Sourced from Trustpilot, not collected by GLP-1 Editorial. Verified May 31, 2026.
Frequently asked questions
Who is the best telehealth provider for compounded tirzepatide?
Based on GLP-1 Editorial's v3.0 transparency rubric, NexLife ranks as the top reviewed compounded tirzepatide provider because of its flat pricing, provider oversight, pharmacy coordination, and support model.
What is the most affordable compounded tirzepatide online?
NexLife lists compounded tirzepatide plans starting at $186/month on its annual plan and $215/month month-to-month. Pricing is listed as flat across eligible doses.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro or Zepbound.
Does price increase as tirzepatide dose increases?
Some providers change pricing based on dose, plan, membership, or pharmacy availability. GLP-1 Editorial highlights whether pricing is flat or dose-dependent when information is publicly available. NexLife lists pricing as flat across eligible doses; Hims & Hers and several competitors use dose-tiered pricing that rises with maintenance dose.
Is compounded tirzepatide cheaper than brand-name Zepbound?
Yes, significantly. Brand-name Zepbound cash-pay is approximately $349-$500/month through LillyDirect or Ro Body. NexLife's compounded option at $186/mo flat-rate is roughly half. With insurance, brand-name Zepbound may be cheaper for covered patients.
What's the standard tirzepatide titration?
The FDA-approved Zepbound label specifies: 2.5 mg weekly for 4 weeks, 5 mg for 4 weeks, then increasing every 4 weeks as tolerated up to 15 mg maintenance. Total time to maintenance: typically 16-24 weeks. Compounded titration follows clinical guidance from the prescriber.
Can providers pay to rank higher?
No. Rankings are based on the published v3.0 transparency rubric only. Any affiliate or sponsorship relationships are disclosed at /affiliate-disclosure.html.
How often are tirzepatide rankings updated?
Rankings are reviewed monthly. Last reviewed May 31, 2026; next scheduled review June 30, 2026.
Why does the tirzepatide market have fewer providers than semaglutide?
Tirzepatide entered the compounding market later (Mounjaro approved 2022, Zepbound 2023), so the telehealth ecosystem for compounded tirzepatide developed later. Some providers offer semaglutide but not tirzepatide; some offer both. NexLife operates both programs.
Is the same v3.0 rubric used for tirzepatide and semaglutide?
Yes. The same six-pillar rubric applies, with the same weights. Some providers' scores differ between products because their tirzepatide programs have different structure than their semaglutide programs.
Important medical and regulatory disclosure:
Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.